Anandaram Sreekanth
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Anandaram Sreekanth has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
Puthiyavalappil Rasin
Department of Chemistry, Sreenidhi University, Hyderabad – 501301, India
15 shared publications- Jebiti Haribabu
Facultad de Medicina, Universidad de Atacama, Los Carreras 1579, 1532502 Copiapo, Chile
10 shared publications Vipin Manakkadan
Department of Chemistry, National Institute of Technology, Tiruchirappalli, 620015, Tamil Nadu, India
10 shared publicationsMoideen Musthafa
Department of Chemistry, National Institute of Technology-Tiruchirappalli, Tiruchirappalli, India
7 shared publicationsVishnunarayanan Namboothiri Vadakkedathu Palakkeezhillam
Department of Chemistry, National Institute of Technology-Tiruchirappalli, Tiruchirappalli, India
7 shared publications- Vaishnu Suresh Kumar
Department of Chemical Engineering, Birla Institute of Technology and Science (BITS), Pilani Campus, Vidya Vihar, Pilani, Rajasthan, 333031, India
6 shared publications
Latest Publications
- Open Access
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Spectroscopic, Electrochemical, Computational, and Biological Investigation of Cu(II), Ni(II), and Zn(II) Complexes of 3-Pyridinecarboxaldehyde Thiosemicarbazone
The new 3-pyridinecarboxaldehyde-based thiosemicarbazone ligand 3-PCTSC and its Cu(II), Ni(II), and Zn(II) complexes were successfully prepared and well characterized in terms of molecular structure, electronic structure, and biological activity. The DNA and BSA binding were investigated through PL and CV, and found to be strong and spontaneous binding (hypothesized to be static quenching) within the molecules. The binding number was highest for the Ni(II) complexes, elucidated to derive from an elongated conjugated system with more electron cloud density and more charge transfer ability; this trend was borne out in the biological activity studies. Electronic distributions and reactive areas characterized through DFT, the ring structures, and frontier molecular orbital evaluation showed good correlation with the bioactivity results. The molecular dockings against the BSA, DNA, and some cancer target proteins produced binding energies that were very promising, with the Ni(II) compound exhibiting the most thermodynamically favorable binding modes with hydrogen bonding, stacking interactions, and metal adjacent binding modes. ADMET calculations gave all the molecules excellent druglikeness, acceptable lipophilicity, high GI absorption, and no abnormal toxic alerts. Due to all these factors, this Ni(II) derivative was the most cytotoxic in an 'in vitro' screening experiment, and more than ten times the potency of the ligand alone and the other two analogues. In summary, the spectroscopic, electrochemical, computational, and biological data altogether unveil the great anticancer efficacy of the nickel(II) complex.
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessSpectroscopic, Electrochemical, Computational, and Biological Investigation of Cu(II), Ni(II), and Zn(II) Complexes of 3-Pyridinecarboxaldehyde Thiosemicarbazone
The new 3-pyridinecarboxaldehyde-based thiosemicarbazone ligand 3-PCTSC and its Cu(II), Ni(II), and Zn(II) complexes were successfully prepared and well characterized in terms of molecular structure, electronic structure, and biological activity. The DNA and BSA binding were investigated through PL and CV, and found to be strong and spontaneous binding (hypothesized to be static quenching) within the molecules. The binding number was highest for the Ni(II) complexes, elucidated to derive from an elongated conjugated system with more electron cloud density and more charge transfer ability; this trend was borne out in the biological activity studies. Electronic distributions and reactive areas characterized through DFT, the ring structures, and frontier molecular orbital evaluation showed good correlation with the bioactivity results. The molecular dockings against the BSA, DNA, and some cancer target proteins produced binding energies that were very promising, with the Ni(II) compound exhibiting the most thermodynamically favorable binding modes with hydrogen bonding, stacking interactions, and metal adjacent binding modes. ADMET calculations gave all the molecules excellent druglikeness, acceptable lipophilicity, high GI absorption, and no abnormal toxic alerts. Due to all these factors, this Ni(II) derivative was the most cytotoxic in an 'in vitro' screening experiment, and more than ten times the potency of the ligand alone and the other two analogues. In summary, the spectroscopic, electrochemical, computational, and biological data altogether unveil the great anticancer efficacy of the nickel(II) complex.
- 3 September 2025
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 62 (11) , 1483-1514
Synthetic Strategies for Selenodiazoles: A Route to Selenium‐Nitrogen Heterocycles
Selenadiazoles, a unique class of selenium‐containing heterocyclic compounds, have attracted considerable interest due to their exceptional structural features and versatile electronic properties. These compounds have demonstrated significant potential across various domains, including medicinal chemistry, materials science, and catalysis. In the realm of pharmaceutical research, selenadiazoles exhibit noteworthy biological activities, such as antimicrobial, anticancer, and antioxidant effects. These properties are largely attributed to the redox‐active selenium center within their molecular framework, which enables modulation of oxidative stress and enzyme activity. As a result, selenadiazoles have emerged as promising candidates for drug discovery and therapeutic development. Beyond their biomedical applications, selenadiazoles play a crucial role in materials science, particularly in the design of organic semiconductors, optoelectronic devices, and luminescent materials. Their tunable electronic characteristics and inherent stability make them valuable building blocks for advanced materials with applications in organic electronics and photonic technologies. In addition, selenadiazoles have proven to be efficient catalysts in organic synthesis, facilitating environmentally benign and selective chemical transformations. Their catalytic efficiency and reusability further underscore their importance in green chemistry. This review presents a comprehensive overview of the synthesis, structural attributes, and functional applications of selenadiazoles, with a particular emphasis on recent advances in their development. A total of 352 selenadiazole compounds are discussed, encompassing all major structural types, including 1,2,3‐selenadiazoles, 1,2,4‐selenadiazoles, 1,2,5‐selenadiazoles, and 1,3,4‐selenadiazoles. The article provides an in‐depth analysis of the latest synthetic methodologies developed between 2015 and 2025, highlighting emerging trends and underscoring the growing significance of selenadiazoles in contemporary scientific research.
- 3 September 2025
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 62 (11) , 1483-1514
Synthetic Strategies for Selenodiazoles: A Route to Selenium‐Nitrogen Heterocycles
Selenadiazoles, a unique class of selenium‐containing heterocyclic compounds, have attracted considerable interest due to their exceptional structural features and versatile electronic properties. These compounds have demonstrated significant potential across various domains, including medicinal chemistry, materials science, and catalysis. In the realm of pharmaceutical research, selenadiazoles exhibit noteworthy biological activities, such as antimicrobial, anticancer, and antioxidant effects. These properties are largely attributed to the redox‐active selenium center within their molecular framework, which enables modulation of oxidative stress and enzyme activity. As a result, selenadiazoles have emerged as promising candidates for drug discovery and therapeutic development. Beyond their biomedical applications, selenadiazoles play a crucial role in materials science, particularly in the design of organic semiconductors, optoelectronic devices, and luminescent materials. Their tunable electronic characteristics and inherent stability make them valuable building blocks for advanced materials with applications in organic electronics and photonic technologies. In addition, selenadiazoles have proven to be efficient catalysts in organic synthesis, facilitating environmentally benign and selective chemical transformations. Their catalytic efficiency and reusability further underscore their importance in green chemistry. This review presents a comprehensive overview of the synthesis, structural attributes, and functional applications of selenadiazoles, with a particular emphasis on recent advances in their development. A total of 352 selenadiazole compounds are discussed, encompassing all major structural types, including 1,2,3‐selenadiazoles, 1,2,4‐selenadiazoles, 1,2,5‐selenadiazoles, and 1,3,4‐selenadiazoles. The article provides an in‐depth analysis of the latest synthetic methodologies developed between 2015 and 2025, highlighting emerging trends and underscoring the growing significance of selenadiazoles in contemporary scientific research.
- 5 August 2025
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 272, 113020
A review on coordination and biological properties of selenosemicarbazone
- 5 August 2025
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 272, 113020
A review on coordination and biological properties of selenosemicarbazone
- 4 June 2025
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 49 (26) , 11531-11547
Functionalized nitro-piperonal thiosemicarbazone based ruthenium( ii )–arene complexes for DNA interaction, anticancer and flow cytometry studies
Functionalized thiosemicarbazones derived from 6-nitro piperonal and their corresponding Ru(II)–(η6-benzene) (RuBNPT, RuBNMT, RuBNCT and RuBNMeT)/(η6-p-cymene) (RuPNPT, RuPNMT, RuPNCT and RuPNMeT) complexes were synthesized and explored for their biological efficacy and anticancer potential. The impact on the complexes’ electronic characteristics, coordination affinity, and bioactivity of the piperonal substitution at the N(4)-position with morpholine (6NMT), pyrrolidine (6NPT), cyclohexyl (6NCT), and N-methyl (6NMeT) groups were investigated. Comprehensive characterization using UV-vis, FT-IR, NMR (1H and 13C), HRMS, and XRD (6NPT and RuPNMT) confirmed the structural integrity of the synthesized compounds. Density functional theory (DFT) calculations revealed insights into electronic and physicochemical properties, while molecular docking studies demonstrated effective binding with the EGFR, suggesting their potential as anticancer agents. DNA and BSA binding studies indicated intercalative and hydrophobic interactions, with RuPNMT exhibiting moderate binding affinity. Cytotoxicity assays, including MTT assay results, indicated the strong activity of the RuPNMT and RuPNPT compounds (RuPNMT and RuPNPT exhibited IC50 values of 10.5 μM and 27.2 μM, respectively, in MDA-MB-231 cells, and 24.6 μM and 58.1 μM in MCF-7 cells). Additionally, apoptosis studies were conducted on these compounds using AO–EB staining and flow cytometry. The presence of heteroatoms and planarity of the N(4)-substituent enhanced the bioactivity of the ligands, while coordination with Ru(II)–arene precursors further amplified their effectiveness. This study underscores the effectiveness of these complexes as promising agents for targeted cancer treatment.
- 4 June 2025
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 49 (26) , 11531-11547
Functionalized nitro-piperonal thiosemicarbazone based ruthenium( ii )–arene complexes for DNA interaction, anticancer and flow cytometry studies
Functionalized thiosemicarbazones derived from 6-nitro piperonal and their corresponding Ru(II)–(η6-benzene) (RuBNPT, RuBNMT, RuBNCT and RuBNMeT)/(η6-p-cymene) (RuPNPT, RuPNMT, RuPNCT and RuPNMeT) complexes were synthesized and explored for their biological efficacy and anticancer potential. The impact on the complexes’ electronic characteristics, coordination affinity, and bioactivity of the piperonal substitution at the N(4)-position with morpholine (6NMT), pyrrolidine (6NPT), cyclohexyl (6NCT), and N-methyl (6NMeT) groups were investigated. Comprehensive characterization using UV-vis, FT-IR, NMR (1H and 13C), HRMS, and XRD (6NPT and RuPNMT) confirmed the structural integrity of the synthesized compounds. Density functional theory (DFT) calculations revealed insights into electronic and physicochemical properties, while molecular docking studies demonstrated effective binding with the EGFR, suggesting their potential as anticancer agents. DNA and BSA binding studies indicated intercalative and hydrophobic interactions, with RuPNMT exhibiting moderate binding affinity. Cytotoxicity assays, including MTT assay results, indicated the strong activity of the RuPNMT and RuPNPT compounds (RuPNMT and RuPNPT exhibited IC50 values of 10.5 μM and 27.2 μM, respectively, in MDA-MB-231 cells, and 24.6 μM and 58.1 μM in MCF-7 cells). Additionally, apoptosis studies were conducted on these compounds using AO–EB staining and flow cytometry. The presence of heteroatoms and planarity of the N(4)-substituent enhanced the bioactivity of the ligands, while coordination with Ru(II)–arene precursors further amplified their effectiveness. This study underscores the effectiveness of these complexes as promising agents for targeted cancer treatment.
- 2 May 2025
- Published by Springer Nature in Journal of Inorganic and Organometallic Polymers and Materials
- Vol. 35 (10) , 8268-8285
Exploring the Biological Efficacy of Zn(II)-Thiosemicarbazone-Ferrocene Complexes: In-Silico and In-Vitro Findings
- 2 May 2025
- Published by Springer Nature in Journal of Inorganic and Organometallic Polymers and Materials
- Vol. 35 (10) , 8268-8285
Exploring the Biological Efficacy of Zn(II)-Thiosemicarbazone-Ferrocene Complexes: In-Silico and In-Vitro Findings
- Open Access
- 28 April 2025
- Published by Springer Nature in Research Square
Zn(II) Complexes of a Novel Twisted Carbon-Centred Scorpionate Derived from Bis(thiadiazole)alkanes (CH2(S-tdzMe)2): Synthesis, Structural Characterization and Protein Interaction Studies
A series of novel zinc(II) halide complexes with the versatile twisted scorpionate ligand, bis((5-methyl-1,3,4-thiadiazol-2-yl)thio)methane (CH2(S-tdzMe)2) (1), have been synthesized and characterized. The ligand (1) reacts with ZnX2 (X = Br, Cl, I) in a 1:1 molar ratio to afford the complexes [Zn(CH2(S-tdzMe)2)X2] (X = I (2), Br (3), Cl (4)). These complexes, along with the ligand, were characterized by elemental analysis, FT-IR, HRESI-MS, UV-Vis, and multinuclear NMR spectroscopy. Single crystal X-ray diffraction studies of the ligand (1) and complex (4) revealed a tetrahedral geometry around the zinc(II) ion with the ligand coordinating in a κ2N-fashion. Preliminary interaction studies with bovine serum albumin (BSA) using fluorescence spectroscopy suggest potential protein-binding capability.
- 28 April 2025
- Published by Springer Nature in Research Square
Open AccessZn(II) Complexes of a Novel Twisted Carbon-Centred Scorpionate Derived from Bis(thiadiazole)alkanes (CH2(S-tdzMe)2): Synthesis, Structural Characterization and Protein Interaction Studies
A series of novel zinc(II) halide complexes with the versatile twisted scorpionate ligand, bis((5-methyl-1,3,4-thiadiazol-2-yl)thio)methane (CH2(S-tdzMe)2) (1), have been synthesized and characterized. The ligand (1) reacts with ZnX2 (X = Br, Cl, I) in a 1:1 molar ratio to afford the complexes [Zn(CH2(S-tdzMe)2)X2] (X = I (2), Br (3), Cl (4)). These complexes, along with the ligand, were characterized by elemental analysis, FT-IR, HRESI-MS, UV-Vis, and multinuclear NMR spectroscopy. Single crystal X-ray diffraction studies of the ligand (1) and complex (4) revealed a tetrahedral geometry around the zinc(II) ion with the ligand coordinating in a κ2N-fashion. Preliminary interaction studies with bovine serum albumin (BSA) using fluorescence spectroscopy suggest potential protein-binding capability.
- 7 April 2025
- Published by Springer Nature in Reaction Kinetics, Mechanisms and Catalysis
- Vol. 138 (4) , 2163-2177
Studies on highly active and low-cost Ni–Fe Bi-metallic catalyst supported on alumina for CO2 hydrogenation reaction
- 7 April 2025
- Published by Springer Nature in Reaction Kinetics, Mechanisms and Catalysis
- Vol. 138 (4) , 2163-2177
Studies on highly active and low-cost Ni–Fe Bi-metallic catalyst supported on alumina for CO2 hydrogenation reaction